Press Releases

29 Jun '22
Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning” CHICAGO --(BUSINESS WIRE)--Jun. 29, 2022-- Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and
05 May '22
First quarter GAAP diluted EPS of $0.17 ; non-GAAP diluted EPS of $0.13 Closed the sale of Hospital & Large Physician Practices business segment to Constellation Software Generated $35 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--May 5, 2022-- Allscripts
21 Apr '22
CHICAGO --(BUSINESS WIRE)--Apr. 21, 2022-- Allscripts Healthcare Solutions, Inc . (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursday, May 5, 2022 . Allscripts management plans to host a conference call and

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com